Task: Answer the multiple choice question.
Question: Which compound exhibits a 12.152% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) Cc1cc(C)c(C(=O)C(C)OC(=O)c2ccc(Cl)nc2)cc1C
b.) Cc1cc(NC(=O)c2ccc(N3CCCC3)c([N+](=O)[O-])c2)no1
Answer: a. Cc1cc(C)c(C(=O)C(C)OC(=O)c2ccc(Cl)nc2)cc1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)c(C(=O)C(C)OC(=O)c2ccc(Cl)nc2)cc1C
Cc1cc(C)c(C(=O)C(C)OC(=O)c2ccc(Cl)nc2)cc1C
[1-oxo-1-(2,4,5-trimethylphenyl)propan-2-yl] 6-chloropyridine-3-carboxylate